Home

The next generation of non-invasive prenatal screening.

Using a simple blood draw from the mother, Panorama™ provides sensitivity >99% and positive predicted value (PPV) > 91% for Down syndrome.  A microdeletion panel (including 22q11.2 deletion syndrome) is also available to provide unparalleled scope and reliability among non-invasive prenatal screens.

 

Expecting Parents
Learn More

Healthcare Providers
Learn More